Bitcoin Group SE

Companies

Bitcoin Group SE (Frankfurt: ADE) is a German publicly listed investment holding company focused on Bitcoin and blockchain technology. Through its subsidiary Bitcoin.de, the company operates one of Europe's largest and oldest peer-to-peer Bitcoin trading platforms, serving retail and institutional traders since 2011. Bitcoin Group SE holds approximately 3,605 BTC on its balance sheet and has been listed on the Frankfurt Stock Exchange since 2015, making it one of Europe's first publicly traded Bitcoin companies.

Details

Ceo: Moritz Eckert
Sector: financial_services
Ticker: ADE
Country: Germany
Notable: Operator of Bitcoin.de, one of Europe's oldest Bitcoin exchanges; one of the first Bitcoin-focused public companies in Europe
Exchange: Frankfurt (Xetra)
Industry: Bitcoin Exchange / Investment
Founded Year: 2015
Headquarters: Frankfurt, Germany
Bitcoin Holdings: 3605
Bitcoin Strategy: Treasury reserve asset; German public company pioneering Bitcoin treasury strategy since 2015
Btc Holdings Date: 2025-02
Bitcoin Holdings Date: 2025-06

Links

twitter

More Companies

Strategy (formerly MicroStrategy)

Strategy (Nasdaq: MSTR), formerly MicroStrategy, is the world's largest corporate Bitcoin holder. Founded by Michael Saylor, the company rebranded in 2025 to reflect its identity as a Bitcoin treasury company. It holds over 500,000 BTC accumulated through equity and debt financing, pioneering the corporate Bitcoin standard that inspired hundreds of companies worldwide.

ACINQ

ACINQ is a French Bitcoin infrastructure company and the developer of Eclair, one of the three major Lightning Network implementations. Founded in 2014, ACINQ builds Phoenix Wallet (a non-custodial Lightning wallet) and operates the ACINQ Lightning node, one of the most well-connected nodes on the Lightning Network.

Acurx Pharmaceuticals

Acurx Pharmaceuticals (NASDAQ: ACXP) is a US biopharmaceutical company that made headlines in November 2021 by adopting Bitcoin as its primary treasury reserve asset — one of the first pharmaceutical companies to do so. The company approved purchasing $1 million in Bitcoin and has continued to hold BTC alongside its drug development pipeline focused on antibiotics. Notable for crossing industry boundaries to embrace the Bitcoin standard.